# A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone

> **NCT04008186** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 61 (actual)

## Conditions studied

- Healthy Adult Subjects

## Interventions

- **DRUG:** Omaveloxolone
- **DRUG:** Midazolam oral solution
- **DRUG:** Repaglinide 1 MG
- **DRUG:** MetFORMIN 500 Mg Oral Tablet
- **DRUG:** Rosuvastatin
- **DRUG:** Digoxin tablet
- **DRUG:** Gemfibrozil Tablets
- **DRUG:** Itraconazole capsule
- **DRUG:** Verapamil Pill

## Key facts

- **NCT ID:** NCT04008186
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-14
- **Primary completion:** 2019-08-18
- **Final completion:** 2019-08-28
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2025-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04008186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04008186, "A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04008186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*